DOMINANT β THALASSAEMIA: MOLECULAR BASIS AND PATHOPHYSIOLOGY

The thalassaemias are a group of inherited haemoglobin disorders characterized by reduced synthesis of 8 globin chains and primarily affecting peoples of Mediterranean. Asian and African ancestry in the malaria-endemic regions. More than 80 mutations causing p thalassaemia have now been characterized (Kazazian, 1990); these result in a deficit of [j chain production that ranges from minimal (mild /I+ thalassaemia alleles) to a complete absence ($ thalassaemia alleles). Typically, heterozygotes for /I thalassaemia, including Po thalassaemia. are clinically asymptomatic with only minor haematological abnormalities, whereas homoaygotes or compound heteroxygotes for /I thalassaemia have thalassaeinia major and are dependent on regulsr blood transfusion for survival (Weatherall & Clegg. 198 1). Therefore, the /j thalassaemias are considered to be autosomal recessive disorders since the inheritance of two abnormal /I globin genes is required to produce a clinically detectable phenotype. Kecently. however, dominant forms of /I thalassaemias have been identified which result in a thalassaemia intermedia phenotype in individuals who have inherited only a single copy of the abnormal p gene. This unusual form of /I’ thalassaemia was probably first identified in an Irish family in 1973: anaemia, enlargement of the spleen, and gross abnormalities of the erythrocytes and their precursors were observed in three generations of the family and were transmitted as a single gene disorder in an autosomal dominant fashion (Weatherall et a!. 1973). The clinical features of severe heterozygous p thalassaemia with a dominant dyserythropoietic anaemia associated with inclusion bodies in bone marrow normoblasts and peripheral red cells after splenectomy were also observed in a Swiss-French family (Stamatoyannopoulos c t a], 1974) and the term ‘inclusion body thalassaemia’ was proposed for this subgroup of 13 thalassaemia. Subsequently, several similarly affected kindreds, from a wide geographical distribution, have been reported. A spectrum of different mutations. underlying these dominantly inherited forms of 8 thalassaemia, have been identified, and it has now become clear that the phenotype of these disorders overlaps both the 8 thalassaemia and the unstable haemoglobin variants.

[1]  S. Thein,et al.  A NOVEL MUTATION (NONSENSE β 127) IN EXON 3 OF THE β GLOBIN GENE PRODUCES A VARIABLE THALASSAEMIC PHENOTYPE , 1991 .

[2]  L. Ribeiro,et al.  Dominant β‐thalassaemia trait in a Portuguese family is caused by a deletion of (G)TGGCTGGTGT(G) and an insertion of (G)GCAG(G) in codons 134, 135, 136 and 137 of the β‐globin gene , 1991 .

[3]  D. Weatherall,et al.  A SPONTANEOUS DELETION OF β33/34 Val IN EXON 2 OF THE β GLOBIN GENE (Hb KOREA) PRODUCES THE PHENOTYPE OF DOMINANT β THALASSAEMIA , 1991 .

[4]  S. Thein,et al.  Hemoglobin Chesterfield (beta 28 Leu----Arg) produces the phenotype of inclusion body beta thalassemia [letter] , 1991 .

[5]  G. Loudianos,et al.  Molecular characterization of beta-thalassemia intermedia in patients of Italian descent and identification of three novel beta-thalassemia mutations. , 1991, Blood.

[6]  A. Cao,et al.  Hemoglobin Cagliari (beta 60 [E4] Val----Glu): a novel unstable thalassemic hemoglobinopathy. , 1991, Blood.

[7]  S. Fucharoen,et al.  Three-base deletion in exon 3 of the beta-globin gene produced a novel variant (beta gunma) with a thalassemia-like phenotype [letter] , 1990 .

[8]  H. Kazazian,et al.  Isolation and characterization of the translation product of a β‐globin gene nonsense mutation (β121 GAA→TAA) , 1990, British journal of haematology.

[9]  K. Miyazono,et al.  A single nucleotide deletion in codon 123 of the β‐globin gene causes an inclusion body β‐thalassaemia trait: a novel elongated globin chain βMakabe , 1990 .

[10]  H. Kazazian The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990. , 1990, Seminars in hematology.

[11]  J. Clegg,et al.  Molecular basis for dominantly inherited inclusion body beta-thalassemia. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Loudianos,et al.  A spontaneous mutation produced a novel elongated beta-globin chain structural variant (Hb Agnana) with a thalassemia-like phenotype. , 1990, Blood.

[13]  G. Stamatoyannopoulos,et al.  One form of inclusion body beta-thalassemia is due to a GAA----TAA mutation at codon 121 of the beta chain. , 1989, Blood.

[14]  A. Kutlar,et al.  Inclusion body beta-thalassemia trait in a Swiss family is caused by an abnormal hemoglobin (Geneva) with an altered and extended beta chain carboxy-terminus due to a modification in codon beta 114. , 1988, Blood.

[15]  N. Komatsu,et al.  A novel globin structural mutant, Showa-Yakushiji (beta 110 Leu-Pro) causing a beta-thalassemia phenotype , 1987 .

[16]  S. Orkin,et al.  Characterization of a spontaneous mutation to a beta-thalassemia allele. , 1986, American journal of human genetics.

[17]  A. Hoffbrand,et al.  Thalassaemia intermedia: a new molecular basis , 1984, British journal of haematology.

[18]  R. Carrell,et al.  Hemoglobin Collingwood β60 (E4) VAL→ALA a New Unstable Hemoglobin , 1983 .

[19]  L. Boxer,et al.  Hemoglobin Indianapolis (beta 112[G14] arginine). An unstable beta-chain variant producing the phenotype of severe beta-thalassemia. , 1979, The Journal of clinical investigation.

[20]  Y. Morino,et al.  A new hemoglobin variant: HB yatsushiro α2Aβ260Val→Leu , 1978 .

[21]  J. Rosa,et al.  Functional and physicochemical studies of hemoglobin St. Louis beta 28 (B10) Leu replaced by Gln: a variant with ferric beta heme iron. , 1976, The Journal of clinical investigation.

[22]  R. Dluhy,et al.  Hemoglobin Cranston, an unstable variant having an elongated beta chain due to nonhomologous crossover between two normal beta chain genes. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Stamatoyannopoulos,et al.  Inclusion-Body β-Thalassemia Trait , 1974 .

[24]  J. Clegg,et al.  A Genetically Determined Disorder with Features both of Thalassaemia and Congenital Dyserythropoietic Anaemia , 1973, British journal of haematology.

[25]  J. Kilmartin,et al.  HÆMOGLOBIN TAK: A VARIANT WITH ADDITIONAL RESIDUES AT THE END OF THE β-CHAINS , 1971 .

[26]  H. Lehmann,et al.  Haemoglobin Genova: β28 (B10) Leucine→Proline , 1967, Nature.